bioRxivMicrobiologyPreprint
A conserved glycan motif overcomes antigenic variation inducing broadly reactive antibodies against the zoonotic pathogen Streptococcus suis
Yao ShiiD, Göran WidmalmiD, Charlotte SorieuliD, Thomas J. RoodsantiD, Jeffrey S. RushiD, Natalia KorotkovaiD, Antonius A. C. JacobsiD, Mirlin P. Spaninks, Ries Grommen, C. Coral Domínguez-MedinaiD, Irene M. SchimmeliD, Nicole N. van der WeliD, Cameron W. Kenner, Christian HeißiD, Parastoo AzadiiD, Li TaniD, Jeroen D. C. CodéeiD, Arjan StegemaniD, Constance SchultsziD, Lindert BenedictusiD, Nina M. van SorgeiD
Abstract
Streptococcus suis is a largely neglected but emerging bacterial zoonotic pathogen of global concern for animal welfare, antibiotic resistance development and human health. No effective vaccines are currently available. Here, we identified and characterized the function and structure of two cell wall polysaccharide variants in pathogenic S. suis strains using genetic deletion and (heterologous) complementation, lectin staining, glycan composition analysis and specialized NMR spectroscopy. Both glycan variants were anionic polymers that differed in the presence of glucose in the side-chain as a result of allelic variation in a glycosyltransferase gene. Deletion of this variable glycosyltransferase revealed an identical glycan core and affected S. suis morphology and lysozyme resistance. Immunization of pigs with this core domain induced antibodies recognizing a wide range of antigenically-diverse pathogenic S. suis strains. This study provides new insights for developing next-generation glycoconjugate vaccines, whereby a single-glycan target could protect against the emerging zoonotic pathogen S. suis.
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- A capsular polysaccharide-expressing live vaccine suppresses streptococcal toxic shock-like syndrome and provides sequence type-independent protection during Streptococcus suis infection
- A semisynthetic glycoconjugate provides expanded cross-serotype protection against Streptococcus pneumoniae
P. M. Kaplonek, L. Yao, … P. H. Seeberger·bioRxiv·Jul 29, 2021
- Regulative synthesis of capsular polysaccharides in the pathogenesis of Streptococcus suis
Xingye Wang, Jie Wang, … Beinan Wang·bioRxiv·Aug 12, 2024
- Examination of Australian Streptococcus suis Isolates From Clinically Affected Pigs in a Global Context and the Genomic Characterisation of ST1 as a Predictor of Virulence
M. A. O'Dea, T. Laird, … S. Abraham·bioRxiv·Jul 24, 2018
- BacScan: An Unbiased and Genome-Wide Approach to Identify Bacterial Highly Immunogenic Proteins
- Development and evaluation of a dual target glycoconjugate vaccine against Shigella sonnei
Catherine L. Hall, Tom Flood, … Brendan William Wren·bioRxiv·Mar 26, 2026